GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
4BQ6 | Q6NW40 | Crystal structure of the RGMB-NEO1 complex form 1 | |
4BQ8 | P97798 | Crystal structure of the RGMB-NEO1 complex form 3 | |
4BQ8 | Q6NW40 | Crystal structure of the RGMB-NEO1 complex form 3 | |
3RG1 | A6QNK7 | Crystal structure of the RP105/MD-1 complex | |
3RG1 | A4IFT3 | Crystal structure of the RP105/MD-1 complex | |
5TOJ | P03420 | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-4 | |
5TOJ | 5TOJ | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-4 | |
5TOJ | P03420 | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-4 | |
5TOJ | 5TOJ | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-4 | |
5TOK | P03420 | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66 | |
5TOK | 5TOK | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66 | |
5TOK | P03420 | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66 | |
5TOK | 5TOK | Crystal structure of the RSV F glycoprotein in complex with the neutralizing single-domain antibody F-VHH-L66 | |
6MG7 | A0A0M3KKW9 | Crystal structure of the RV144 C1-C2 specific antibody CH54 Fab in complex with HIV-1 CLADE A/E GP120 and M48U1 | |
6MG7 | 6MG7 | Crystal structure of the RV144 C1-C2 specific antibody CH54 Fab in complex with HIV-1 CLADE A/E GP120 and M48U1 | |
4G9N | 4G9N | Crystal structure of the Rhizoctonia solani agglutinin in complex with N'-acetyl-galactosamine | |
4I47 | D9J2T9 | Crystal structure of the Ribosome inactivating protein complexed with methylated guanine | |
4ADG | 4ADG | Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II) | |
4ADG | P08563 | Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II) | |
4ADG | 4ADG | Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II) | |
4ADG | P08563 | Crystal structure of the Rubella virus envelope Glycoprotein E1 in post-fusion form (crystal form II) | |
4ADI | P08563 | Crystal structure of the Rubella virus envelope glycoprotein E1 in post-fusion form (crystal form I) | |
4ADI | 4ADI | Crystal structure of the Rubella virus envelope glycoprotein E1 in post-fusion form (crystal form I) | |
4ADI | P08563 | Crystal structure of the Rubella virus envelope glycoprotein E1 in post-fusion form (crystal form I) | |
4ADI | 4ADI | Crystal structure of the Rubella virus envelope glycoprotein E1 in post-fusion form (crystal form I) | |
4ADJ | P08563 | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate | |
4ADJ | 4ADJ | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate | |
4ADJ | P08563 | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate | |
4ADJ | 4ADJ | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 1mM of calcium acetate | |
4B3V | P08563 | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate | |
4B3V | 4B3V | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate | |
4B3V | P08563 | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate | |
4B3V | 4B3V | Crystal structure of the Rubella virus glycoprotein E1 in its post-fusion form crystallized in presence of 20mM of Calcium Acetate | |
6WAQ | 6WAQ | Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72 | |
6WAQ | P59594 | Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72 | |
8QH1 | A0A8A5XRG7 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
8QH1 | 8QH1 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
8QH1 | Q6PJF2 | Crystal structure of the SARS-CoV-2 RBD from the Omicron BA4 variant with the antibody Cv2.3194 | |
7CHB | 7CHB | Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab | |
7CHB | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with BD-236 Fab | |
7B3O | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab | |
7B3O | 7B3O | Crystal structure of the SARS-CoV-2 RBD in complex with STE90-C11 Fab | |
7VNB | 7VNB | Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 | |
7VNB | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113 | |
7QF0 | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325 | |
7QF0 | 7QF0 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.2325 | |
7QF1 | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 | |
7QF1 | 7QF1 | Crystal structure of the SARS-CoV-2 RBD in complex with the human antibody CV2.6264 | |
7QEZ | P0DTC2 | Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022 | |
7QEZ | 7QEZ | Crystal structure of the SARS-CoV-2 RBD in complex with the ultrapotent antibody CV2.1169 and CR3022 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024